Study to Evaluate Safety & Effectiveness of Spinal Sealant

NCT ID: NCT00444067

Last Updated: 2017-09-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

98 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-05-31

Study Completion Date

2009-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate a spinal sealant as an adjunct to sutured dural repair compared to standard of care techniques.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neurosurgical procedures in the spine often involve incision of the dura mater to access the spinal cord. If the dural incision is not properly repaired and watertight closure is not achieved cerebrospinal fluid (CSF) can escape presenting a risk for significant morbidity. The most frequent complication of CSF leak is recurring headache complicated with symptoms of nausea and vomiting. Furthermore fluid collection under skin prevents proper wound healing and may lead to wound breakdown and infection of the incision or both. Persistent CSF leak has also been associated with the development of cerebellar hemorrhage and subdural hematoma. Primary repair and watertight closure are paramount to minimizing risk and sequelae associated with CSF leak.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebrospinal Fluid Leakage, Subdural

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spinal Sealant System

Spinal Sealant System

Group Type EXPERIMENTAL

Spinal Sealant

Intervention Type DEVICE

Spinal Sealant System

Standard of Care

Standard of care methods as an adjunct to sutured dural repair

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

Standard of Care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spinal Sealant

Spinal Sealant System

Intervention Type DEVICE

Standard of Care

Standard of Care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects scheduled for a spinal procedure that requires a dural incision
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic - MITG

INDUSTRY

Sponsor Role collaborator

Integra LifeSciences Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jen Doyle

Role: STUDY_DIRECTOR

Conlfuent Surgical/Covidien

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Confluent Surgical, Inc.

Bedford, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Wright NM, Park J, Tew JM, Kim KD, Shaffrey ME, Cheng J, Choudhri H, Krishnaney AA, Graham RS, Mendel E, Simmons N. Spinal sealant system provides better intraoperative watertight closure than standard of care during spinal surgery: a prospective, multicenter, randomized controlled study. Spine (Phila Pa 1976). 2015 Apr 15;40(8):505-13. doi: 10.1097/BRS.0000000000000810.

Reference Type DERIVED
PMID: 25646746 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DS3-06-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The EVICEL® Neurosurgery Phase III Study
NCT02457546 COMPLETED PHASE3
Stem Cell Therapy in Spinal Cord Injury
NCT02009124 WITHDRAWN PHASE2
CraniSeal Post Approval Study
NCT06406790 RECRUITING PHASE4
Cell Transplant in Spinal Cord Injury Patients
NCT00816803 COMPLETED PHASE1/PHASE2